|
1
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4422006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sohal SS, Ward C, Danial W, Wood-Baker R
and Walters EH: Recent advances in understanding inflammation and
remodeling in the airways in chronic obstructive pulmonary disease.
Expert Rev Respir Med. 7:275–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogg JC, Chu F, Utokaparch S, Woods R,
Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson
HO and Paré PD: The nature of small-airway obstruction in chronic
obstructive pulmonary disease. N Engl J Med. 350:2645–2653. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sohal SS and Walters EH: Role of
epithelial mesenchymal transition (EMT) in chronic obstructive
pulmonary disease (COPD). Respir Res. 14:1202013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Milara J, Peiró T, Serrano A and Cortijo
J: Epithelial to mesenchymal transition is increased in patients
with COPD and induced by cigarette smoke. Thorax. 68:410–420. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Q, Wang Y, Zhang Y, Zhang Y and Xiao
W: The role of uPAR in epithelial-mesenchymal transition in small
airway epithelium of patients with chronic obstructive pulmonary
disease. Respir Res. 14:672013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nowrin K, Sohal SS, Peterson G, Patel R
and Walters EH: Epithelial-mesenchymal transition as a fundamental
underlying pathogenic process in COPD airways: Fibrosis, remodeling
and cancer. Expert Rev Respir Med. 8:547–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sohal SS, Mahmood MQ and Walters EH:
Clinical significance of epithelial mesenchymal transition (EMT) in
chronic obstructive pulmonary disease (COPD): Potential target for
prevention of airway fibrosis and lung cancer. Clin Transl Med.
3:332014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gohy ST, Hupin C, Fregimilicka C, Detry
BR, Bouzin C, Chevronay Gaide H, Lecocq M, Weynand B, Ladjemi MZ,
Pierreux CE, et al: Imprinting of the COPD airway epithelium for
dedifferentiation and mesenchymal transition. Eur Respir J.
45:1258–1272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holgate ST: The sentinel role of the
airway epithelium in asthma pathogenesis. Immunol Rev. 242:205–219.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Isailovic N, Daigo K, Mantovani A and
Selmi C: Interleukin-17 and innate immunity in infections and
chronic inflammation. J Autoimmun. 60:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Stefano A, Caramori G, Gnemmi I,
Contoli M, Vicari C, Capelli A, Magno F, D'Anna SE, Zanini A, Brun
P, et al: T helper type 17-related cytokine expression is increased
in the bronchial mucosa of stable chronic obstructive pulmonary
disease patients. Clin Exp Immunol. 157:316–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doe C, Bafadhel M, Siddiqui S, Desai D,
Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, et al:
Expression of the T helper 17-associated cytokines IL-17A and
IL-17F in asthma and COPD. Chest. 138:1140–1147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eustace A, Smyth LJC, Mitchell L,
Williamson K, Plumb J and Singh D: Identification of cells
expressing IL-17A and IL-17F in the lungs of patients with COPD.
Chest. 139:1089–1100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Montalbano AM, Riccobono L, Siena L,
Chiappara G, Di Sano C, Anzalone G, Gagliardo R, Ricciardolo FLM,
Sorbello V, Pipitone L, et al: Cigarette smoke affects IL-17A,
IL-17F and IL-17 receptor expression in the lung tissue: Ex vivo
and in vitro studies. Cytokine. 76:391–402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baker CL, Zou KH and Su J: Long-acting
bronchodilator use after hospitalization for COPD: An observational
study of health insurance claims data. Int J Chron Obstruct Pulmon
Dis. 9:431–439. 2014.PubMed/NCBI
|
|
17
|
Wang G, Zhou H, Strulovici-Barel Y,
Al-Hijji M, Ou X, Salit J, Walters MS, Staudt MR, Kaner RJ and
Crystal RG: Role of OSGIN1 in mediating smoking-induced autophagy
in the human airway epithelium. Autophagy. 13:1205–1220. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hogan AE, Corrigan MA, O'Reilly V,
Gaoatswe G, O'Connell J, Doherty DG, Lynch L and O'Shea D:
Cigarette smoke alters the invariant natural killer T cell function
and may inhibit anti-tumor responses. Clin Immunol. 140:229–235.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kosmider B, Messier EM, Chu HW and Mason
RJ: Human alveolar epithelial cell injury induced by cigarette
smoke. PLoS One. 6:e260592011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nowrin K, Sohal SS, Peterson G, Patel R
and Walters EH: Epithelial-mesenchymal transition as a fundamental
underlying pathogenic process in COPD airways: Fibrosis, remodeling
and cancer. Expert Rev Respir Med. 8:547–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caramori G, Adcock IM, Di Stefano A and
Chung KF: Cytokine inhibition in the treatment of COPD. Int J Chron
Obstruct Pulmon Dis. 9:397–412. 2014.PubMed/NCBI
|
|
23
|
Zhang X, Zheng H, Zhang H, Ma W, Wang F,
Liu C and He S: Increased interleukin (IL)-8 and decreased IL-17
production in chronic obstructive pulmonary disease (COPD) provoked
by cigarette smoke. Cytokine. 56:717–725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang Y, Al-Alwan L, Alshakfa S, Audusseau
S, Mogas AK, Chouiali F, Nair P, Baglole CJ, Hamid Q and Eidelman
DH: Upregulation of IL-17A/F from human lung tissue explants with
cigarette smoke exposure: Implications for COPD. Respir Res.
15:1452014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roos AB, Sandén C, Mori M, Bjermer L,
Stampfli MR and Erjefält JS: IL-17A is elevated in End-stage
chronic obstructive pulmonary disease and contributes to cigarette
smoke-induced lymphoid neogenesis. Am J Respir Crit Care Med.
191:1232–1241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Chu S, Zhong X, Lao Q, He Z and
Liang Y: Increased expression of CD4+IL-17+ cells in the lung
tissue of patients with stable chronic obstructive pulmonary
disease (COPD) and smokers. Int Immunopharmacol. 15:58–66. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Chu S, Zhong X, Lao Q, He Z and
Liang Y: Increased expression of CD4+IL-17+ cells in the lung
tissue of patients with stable chronic obstructive pulmonary
disease (COPD) and smokers. Int Immunopharmacol. 15:58–66. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin Y, Wan Y, Chen G, Chen L, Zhang MQ,
Deng L, Zhang JC, Xiong XZ and Xin JB: Treg/IL-17 ratio and Treg
differentiation in patients with COPD. PLoS One. 9:e1110442014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu Q, Jiang D and Chu HW: Cigarette smoke
induces growth differentiation factor 15 production in human lung
epithelial cells: Implication in mucin over-expression. Innate
Immun. 18:617–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim M, Cha SI, Choi KJ, Shin KM, Lim JK,
Yoo SS, Lee J, Lee SY, Kim CH, Park JY, et al: Prognostic value of
serum growth differentiation factor-15 in patients with chronic
obstructive pulmonary disease exacerbation. Tuberc Respir Dis
(Seoul). 77:243–250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patel MS, Lee J, Baz M, Wells CE, Bloch S,
Lewis A, Donaldson AV, Garfield BE, Hopkinson NS, Natanek A, et al:
Growth differentiation factor-15 is associated with muscle mass in
chronic obstructive pulmonary disease and promotes muscle wasting
in vivo. J Cachexia Sarcopenia Muscle. 7:436–448. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Husebo GR, Grønseth R, Lerner L, Gyuris J,
Hardie JA, Bakke PS and Eagan TM: Growth differentiation factor-15
is a predictor of important disease outcomes in patients with COPD.
Eur Respir J. 49:pii: 1601298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verhamme FM, Seys LJ, De Smet EG, Provoost
S, Janssens W, Elewaut D, Joos GF, Brusselle GG and Bracke KR:
Elevated GDF-15 contributes to pulmonary inflammation upon
cigarette smoke exposure. Mucosal Immunol. 10:1400–1411. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Freeman CM, Martinez CH, Todt JC, Martinez
FJ, Han MK, Thompson DL, McCloskey L and Curtis JL: Acute
exacerbations of chronic obstructive pulmonary disease are
associated with decreased CD4+ &; CD8+ T cells and increased
growth &; differentiation factor-15 (GDF-15) in peripheral
blood. Respir Res. 16:942015. View Article : Google Scholar : PubMed/NCBI
|
